Second vote and conclusions

Date 29 September 2014
Event ESMO 2014
Session Docetaxel is the standard of care for metastatic prostate cancer patients starting Androgen deprivation therapy (ADT)
Topics Cytotoxic agents
Prostate Cancer
Therapy
Biological therapy
Presenter Eleni Efstathiou
Authors E. Efstathiou
  • Oncology, University of Texas MD Anderson Cancer Center, TX77030 - HOUSTON/US